HC Wainwright & Co. Reiterates Buy on Rallybio, Maintains $6 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Rallybio (NASDAQ:RLYB) and maintained a price target of $6, as per analyst Mitchell Kapoor.
October 30, 2024 | 12:26 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Rallybio and maintained a $6 price target, indicating confidence in the company's future performance.
The reiteration of a Buy rating and maintenance of a $6 price target by a reputable analyst firm like HC Wainwright & Co. suggests positive sentiment and confidence in Rallybio's future performance, likely leading to a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100